Headquartered in Edmonton, Alberta, Canada, IMBiotechnologies Ltd. is a privately-owned biotechnology company focused on the development and commercialization of medical devices in the area of embolotherapy. The Company’s core technology is designed for the treatment of solid malignant tumors, benign tumors such as uterine fibroids, benign prostatic hyperplasia (“BPH”), and other tissues.